For most of us, the idea that a very small amount of psilocybin could alter the way we think, feel, and move through the day sounds almost too simple. Yet that is exactly what microdosing does — or at least, what it gently invites. For centuries, psilocybin has been used in rituals and ceremonies as a tool for healing and insight. Today, modern science is beginning to catch up, showing us how even small amounts interact with the brain in meaningful ways.
But here's the truth: the effects of microdosing are not about hallucinations or dramatic visions. They lie in subtle shifts — a lighter mood, a quieter inner critic, a little more creative flow. To understand microdosing, it helps to understand what's actually happening when psilocybin enters the body.
So let's explore: what microdosing is, where it came from, how it works, and why people do it.
What Microdosing Actually Is
Microdosing means taking a sub-perceptual dose of a psychedelic substance — typically around one-tenth of a full psychedelic dose. At this level, there are no hallucinations, no altered perception of reality. The changes are subtle enough that most people can go about their normal day.
The most common substance used for microdosing is psilocybin, found in psychedelic mushrooms and truffles. At myco, we work exclusively with psilocybin truffles (Psilocybe tampanensis), which are legal in the Netherlands and can be shipped across the EU.
But microdosing is more than just the amount you take. It's a practice — built on intention, rhythm, and integration into daily life. The dose is the spark. What you do with it is what shapes the journey.
The Origins of Microdosing
The idea of working with small amounts of psychedelics is not new. Long before the term "microdosing" existed, indigenous cultures were using mushrooms, cacti, and other plants in carefully calibrated doses — not always for high-dose ceremonial experiences, but sometimes simply to open the senses or ease the mind.
What changed in modern times was the language and the science. In the 2000s, psychologist Dr. James Fadiman began systematically documenting what happened when people took very small doses of psychedelics over extended periods. His book, The Psychedelic Explorer's Guide (2011), became the blueprint for the modern microdosing movement. Fadiman introduced structured protocols — one day on, two days off — combined with journaling and self-reflection. Thousands of people began experimenting and sharing their results.
Today, that movement has crossed into mainstream culture. Professionals use it for focus. Therapists explore it as a mental health tool. Everyday people try it to soften anxiety, reconnect with creativity, or simply feel a little more present.
From Truffle to Molecule: How Psilocybin Works
When you consume a psilocybin truffle, the active ingredient isn't immediately "psychedelic." Psilocybin is what scientists call a prodrug — inactive until your body transforms it. Once digested, enzymes quickly convert psilocybin into psilocin, the true active compound.
Psilocin's molecular structure is nearly identical to serotonin, one of the brain's most important neurotransmitters. Because of this similarity, psilocin can fit into the same receptors — particularly the 5-HT2A subtype, concentrated in the prefrontal cortex, the region responsible for complex thought, planning, and self-reflection. It's like a forged key that still opens the lock.
Within 20 to 40 minutes of ingestion, psilocin crosses the blood-brain barrier and begins adjusting the conversation inside your brain. Even at microdoses, this process is happening — the amount is simply smaller, so the effects remain subtle rather than perceptual.
Quieting the Default Mode Network
One of the most significant discoveries in psychedelic neuroscience is psilocybin's effect on the default mode network (DMN).
The DMN is active when we're not focused on the outside world — when we're daydreaming, ruminating, or caught in loops of self-criticism. In many ways, it underpins our sense of ego. When the DMN is overactive, we get stuck: trapped in repetitive thought patterns, anxiety, or the heavy cycles of depression.
Under psilocybin, activity in the DMN decreases. At the same time, communication between brain regions that normally operate separately increases. Think of your brain like a city where most traffic is funneled through a few main highways. Psilocybin temporarily opens up dozens of side streets. New neighborhoods connect. Ideas that never "met" begin to flow together.
Even at microdoses, these effects can show up subtly: a lighter inner dialogue, less harsh self-criticism, a small but meaningful shift in how you relate to yourself and others.
Neuroplasticity: Building New Pathways
One of the most promising areas of research is psilocybin's role in neuroplasticity — the brain's ability to rewire itself.
Animal studies show that psilocybin promotes the growth of new dendritic spines, the small branches that connect neurons. In some cases, these new connections persist weeks after the psilocybin is gone. This suggests that psilocybin doesn't just create temporary effects — it may help the brain form lasting new pathways.
For microdosing, repeated small exposures may gently encourage healthier patterns over time: making it easier to build positive habits, shift perspectives, or feel more resilient. Neuroplasticity is the hidden bridge — the reason psilocybin's effects can last far longer than the experience itself.
Why People Microdose
If you ask ten people why they microdose, you'll get ten different answers. But across thousands of self-reports, some themes repeat again and again.
- Focus and flow: A steady clarity without the jitter of caffeine or the crash of sugar. Writers finish drafts. Professionals enter flow states more easily.
- Mood and anxiety relief: A background shift — less anxious chatter, more emotional balance. Not euphoria, but a lighter relationship with daily stress.
- Creativity: Mental rigidity softens, making room for new connections. It's not that creativity is "created" — it's that the obstacles to it dissolve.
- Connection and relationships: More patience, more empathy, more presence in conversations. Small shifts here can ripple into deeper trust.
- Presence and well-being: For some, microdosing isn't about productivity at all. It's about feeling more alive and more in touch with the day.
Of course, microdosing is not a cure-all. But it can act as a catalyst — a spark that makes it easier to build the habits and perspectives that support well-being.
The Practice: Protocols and Integration
What makes microdosing meaningful is the practice built around it — the rhythm and intention that turn a small dose into a real tool.
The most common approach is the Fadiman protocol: one day on, two days off, repeated over several weeks. This prevents tolerance from building and creates space to notice subtle effects. Some adapt the protocol to fit their own lives — microdosing once or twice a week, or following cycles aligned with creative projects or personal goals.
Equally important is integration — weaving the insights and shifts from microdosing into daily life through journaling, reflection, or simply paying attention. The truffle creates a window. What you do with that window is what matters.
At myco, this is exactly what our journeys are built around. Each 30-day program pairs psilocybin truffles with a structured daily practice designed to help you make the most of every dose — not just on dosing days, but every day.
Final Thoughts
So what is microdosing? It's the practice of working with psilocybin in its gentlest form — small steps that open big possibilities. Not a shortcut. Not an escape. A partnership between biology and intention.
The truffle provides the spark. The practice provides the direction. Together, they create the conditions for more clarity, creativity, and connection in daily life.
Microdosing is not about seeing the world differently. It's about living in it more fully.
Further Reading
- Fadiman, J. (2011). The Psychedelic Explorer's Guide: Safe, Therapeutic, and Sacred Journeys. Simon & Schuster.
- Polito, V. & Stevenson, R. J. (2019). A systematic study of microdosing psychedelics. PLOS ONE.
- Rootman, J. M. et al. (2021). Adults who microdose psychedelics report health-related motivations and lower levels of anxiety and depression compared to non-microdosers. Scientific Reports.
- Kuypers, K. P. C. et al. (2019). Microdosing psychedelics: More questions than answers? Journal of Psychopharmacology.